Wednesday, July 29, 2020

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir The drug, priced at 59 rupees (79 cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.

from Moneycontrol Business News https://ift.tt/2Dfe7Pg

No comments:

Post a Comment

Oil prices may face further pressure amid OPEC+ supply glut: Seth R Freeman

Seth R Freeman of GlassRatner Advisory notes India's role in stabilizing oil prices by purchasing discounted Russian oil amidst tariff a...